The Center for Disease Control (CDC) defines a Closed System Drug-Transfer Device (CSTD) as a drug-transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system.
Equashield brings to market the only closed-back Syringe Unit, protecting from rod plunger contamination and the release of hazardous particles from the back of the syringe. Specifically, EQUASHIELD® syringe units maintain a closed pressure equalization that prevents the escape of vapors and aerosols during compounding and administration.
This unique dual-needle, air-to-liquid exchange system—combined with a closed-back sterile air chamber behind the syringe—ensures that pressure is equalized in a system throughout the hazardous drug handling process.
Unlike bulky balloon systems, EQUASHIELD® has streamlined the design, making it sleek and easy to use. This intuitive tool saves valuable time during preparation and administration.
At EQUASHIELD® our mission is to provide superior solutions for the protection of healthcare workers worldwide. Our state of the art devices are carefully designed, easy to use, and reduce the risk of hazardous drug exposure.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Compounding: Closed System Drug-Transfer Devices (CSTDs)
